HKEX Insider Activity — 2026-07-17

by hk-insider-activities-daily

🇭🇰 HKEX DI Report — 2026-07-17

🆕 NEW ENTRY — 668 Anker Innovations (H) ← J.P. Morgan Securities, first filing at 6.91% (new position, ~3.22M shares @ avg HKD 99.30, ~HKD 320M) Read: JP Morgan crossed the 5% disclosure threshold in Anker Innovations H-shares for the first time, building a fresh 6.91% long stake worth ~HKD 320M.

🆕 NEW ENTRY — 668 Anker Innovations (H) ← Bank of New York Mellon, now at 5.24% (increased by 4.40pp, internal restructure) Read: A BNY Mellon sub-entity filed a 1004 "ceased interest" notice while the consolidated group stake rose 4.40pp to 5.24%, indicating an intra-group reallocation rather than open-market buying.

🆕 NEW ENTRY — 2210 Beijing Capital Jiaye Property Services (H) ← Farrich Investments, now at 5.11% (increased by 0.25pp, ~90K shares @ HKD 1.8158, ~HKD 163K triggering trade) Read: Farrich Investments crossed the 5% threshold in Beijing Capital Jiaye H-shares, disclosing a 5.11% aggregate built across a small open-market buy and a larger existing position.

🆕 NEW ENTRY — 2210 Beijing Capital Jiaye Property Services (H) ← Thebest Investments, now at 5.11% (increased by 0.25pp, ~90K shares @ HKD 1.8158, ~HKD 163K triggering trade) Read: Thebest Investments filed identically to Farrich on the same date at the exact same 5.11% aggregate, strongly suggesting both entities share a common beneficial owner whose combined stake triggered simultaneous threshold disclosures.

🆕 NEW ENTRY — 6951 Chaozhou Three-Circle (H) ← JPMorgan Asset Management (Asia Pacific), first filing at 8.19% (new consolidated position, ~5.84M shares @ avg HKD 100.30, ~HKD 586M) Read: JPMAM Asia Pacific lodged its first disclosure in Chaozhou Three-Circle H-shares following a group restructure, registering a substantial 8.19% consolidated stake worth ~HKD 586M.

🆕 NEW ENTRY — 3986 GigaDevice Semiconductor (H) ← JPMorgan Chase, now at 10.64% (increased by 8.68pp, internal restructure, ~2.89M shares @ avg HKD 649.94, ~HKD 1.88B) Read: JPMorgan Chase consolidated its GigaDevice Semiconductor H-share position after a sub-entity restructure, pushing the aggregate stake to a dominant 10.64%—with the restructured tranche alone valued at ~HKD 1.88B.

🆕 NEW ENTRY — 1143 China Energy Storage Technology Development ← Lau Shing Ngon, first filing at 15.35% (~34.4M shares @ HKD 0.445, ~HKD 15.3M) Read: Individual investor Lau Shing Ngon emerged with a 15.35% first-disclosure in this small-cap energy-storage name for ~HKD 15.3M—a substantial proportionate stake worth watching for follow-on activity or a strategic angle.

🆕 NEW ENTRY — 2208 Goldwind Science & Technology (H) ← Bank of America, now at 6.17% (increased by 4.01pp, internal restructure) Read: Bank of America's 1004 filing on Goldwind H-shares consolidated a scattered group position; the aggregate jumped 4.01pp to 6.17% through intra-group restructuring, not open-market wind-energy accumulation.

🆕 NEW ENTRY — 65 Grand Ocean Advanced Resources ← Liu Changyou, first filing at 6.45% (~15.84M shares @ HKD 0.195, ~HKD 3.1M) Read: Liu Changyou filed a first 5%-plus disclosure at 6.45% in micro-cap Grand Ocean Advanced Resources for ~HKD 3.1M—a name thin enough that even a small position warrants monitoring for strategic intent.

🆕 NEW ENTRY — 525 Guangshen Railway (H) ← E Fund Management, now at 6.16% (increased by 0.19pp, ~2.67M shares @ avg HKD 2.17, ~HKD 5.8M) Read: E Fund Management (易方达) crossed the 5% disclosure bar in Guangshen Railway H-shares with a modest HKD 5.8M incremental buy, consistent with index or sector positioning by one of China's largest fund houses.

🆕 NEW ENTRY — 1179 H World Group (S) ← Mitsubishi UFJ Financial Group (MUFG), now at 5.02% (increased by 0.05pp, ~1.51M shares @ avg HKD 32.11, ~HKD 48.3M) Read: MUFG barely cleared the 5% notification bar in H World Group with a 0.05pp increment, a textbook passive-index rebalance rather than a high-conviction new position.

🆕 NEW ENTRY — 1519 J&T Global Express (W) ← JPMorgan Chase, now at 5.57% (increased by 0.95pp, internal restructure, ~83.4M shares @ avg HKD 9.09, ~HKD 757M) Read: JPMorgan Chase's 1004 filing on J&T Global Express W-shares reflects an intra-group entity restructure; the ~HKD 757M tranche moved internally confirms no fresh open-market buying despite the 0.95pp aggregate increase to 5.57%.

🆕 NEW ENTRY — 8331 P.B. Group ← P.B. Capital Group, first filing at 17.28% (~27.5M shares @ HKD 0.255, ~HKD 7M) Read: P.B. Capital Group—whose name mirrors the listed entity—filed its first 5%-plus disclosure at a dominant 17.28%, strongly suggesting a controlling or strategic stake rather than a passive financial investment.

🆕 NEW ENTRY — 808 Prosperity REIT ← Vanguard Capital Management, now at 5.04% (increased by 0.12pp) Read: Vanguard crossed the 5% threshold in Prosperity REIT with a 0.12pp increment and no disclosed trade price, a textbook passive-index adjustment into this HK commercial-property trust.

🆕 NEW ENTRY — 9626 Bilibili (W) ← BlackRock, now at 5.04% (increased by 0.14pp, internal restructure) Read: BlackRock's 1004 filing for Bilibili-W reflects a minor intra-group reallocation; the aggregate nudged up 0.14pp to 5.04% with no price disclosed, not a new directional bet.

🆕 NEW ENTRY — 552 China Communications Services (H) ← BlackRock, now at 5.05% (increased by 0.20pp, internal restructure) Read: A second BlackRock 1004 restructure, this time in China Comms Services H-shares; the consolidated stake ticked up 0.20pp to 5.05% on a paperwork reallocation with no price disclosed.

🆕 NEW ENTRY — 719 Shandong Xinhua Pharmaceutical (H) ← E Fund Management, now at 6.16% (increased by 0.41pp, ~790K shares @ avg HKD 6.06, ~HKD 4.8M) Read: E Fund Management also crossed the 5% mark in Shandong Xinhua Pharma H-shares on the same day as its Guangshen Railway buy, adding ~HKD 4.8M to reach 6.16%—broad A-H sector positioning in the same filing window.

🏢 BUYBACK — 6821 Asymchem Laboratories (H) ← Barclays, now at 6.23% (decreased by 0.80pp) Read: Asymchem's ongoing buyback programme trimmed Barclays' proportionate stake by 0.80pp to 6.23%; the decrease implies Barclays tendered shares into the buyback rather than selling on-market.

🏢 BUYBACK — 3696 InSilico Medicine ← JPMorgan Chase, now at 5.45% (decreased by 0.55pp, ~3.17M shares @ avg HKD 44.47, ~HKD 141M) Read: InSilico Medicine repurchased ~3.17M shares at avg HKD 44.47 (~HKD 141M), mechanically reducing JPMorgan's stake by 0.55pp to 5.45%—notable capital return activity for a company still in clinical-stage development.